These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14667926)

  • 1. Glucuronidation as a mechanism of intrinsic drug resistance in colon cancer cells: contribution of drug transport proteins.
    Cummings J; Zelcer N; Allen JD; Yao D; Boyd G; Maliepaard M; Friedberg TH; Smyth JF; Jodrell DI
    Biochem Pharmacol; 2004 Jan; 67(1):31-9. PubMed ID: 14667926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced clearance of topoisomerase I inhibitors from human colon cancer cells by glucuronidation.
    Cummings J; Boyd G; Ethell BT; Macpherson JS; Burchell B; Smyth JF; Jodrell DI
    Biochem Pharmacol; 2002 Feb; 63(4):607-13. PubMed ID: 11992628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon.
    Cummings J; Ethell BT; Jardine L; Burchell B
    Anticancer Res; 2006; 26(3B):2189-96. PubMed ID: 16821585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives.
    Cummings J; Ethell BT; Jardine L; Boyd G; Macpherson JS; Burchell B; Smyth JF; Jodrell DI
    Cancer Res; 2003 Dec; 63(23):8443-50. PubMed ID: 14679008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3.
    Chu XY; Huskey SE; Braun MP; Sarkadi B; Evans DC; Evers R
    J Pharmacol Exp Ther; 2004 Apr; 309(1):156-64. PubMed ID: 14722317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.
    Qin Z; Li S; Yao Z; Hong X; Wu B; Krausz KW; Gonzalez FJ; Gao H; Yao X
    Food Funct; 2018 Mar; 9(3):1410-1423. PubMed ID: 29318243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant tumor cells remain sensitive to a recombinant interleukin-4-Pseudomonas exotoxin, except when overexpressing the multidrug resistance protein MRP1.
    de Jong MC; Scheffer GL; Broxterman HJ; Hooijberg JH; Slootstra JW; Meloen RH; Kreitman RJ; Husain SR; Joshi BH; Puri RK; Scheper RJ
    Clin Cancer Res; 2003 Oct; 9(13):5009-17. PubMed ID: 14581376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin.
    Liu W; Feng Q; Li Y; Ye L; Hu M; Liu Z
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):316-24. PubMed ID: 22982073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the major metabolite of the novel topoisomerase I inhibitor NU/ICRF 505.
    Cummings J; Meikle I; Macpherson JS; Smyth JF
    Anticancer Drug Des; 1996 Jul; 11(5):367-82. PubMed ID: 8765530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells.
    Brangi M; Litman T; Ciotti M; Nishiyama K; Kohlhagen G; Takimoto C; Robey R; Pommier Y; Fojo T; Bates SE
    Cancer Res; 1999 Dec; 59(23):5938-46. PubMed ID: 10606239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1.
    Zhang B; Yang J; Qin Z; Li S; Xu J; Yao Z; Zhang X; Gonzalez FJ; Yao X
    PLoS One; 2019; 14(5):e0217695. PubMed ID: 31150474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic study on the intestinal absorption and disposition of baicalein.
    Zhang L; Lin G; Kovács B; Jani M; Krajcsi P; Zuo Z
    Eur J Pharm Sci; 2007 Jul; 31(3-4):221-31. PubMed ID: 17507208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
    Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
    Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides.
    Xu H; Kulkarni KH; Singh R; Yang Z; Wang SW; Tam VH; Hu M
    Mol Pharm; 2009; 6(6):1703-15. PubMed ID: 19736994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis in human cancer cell lines by the novel anthracenyl-amino acid topoisomerase I inhibitor NU/ICRF 505.
    Meikle I; Cummings J; Macpherson JS; Smyth JF
    Br J Cancer; 1996 Aug; 74(3):374-9. PubMed ID: 8695351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney.
    Li CY; Basit A; Gupta A; Gáborik Z; Kis E; Prasad B
    J Steroid Biochem Mol Biol; 2019 Jul; 191():105350. PubMed ID: 30959153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Efflux Transporter Affinity and Metabolism of
    Kobayashi M; Tsujiuchi T; Okui Y; Mizutani A; Nishi K; Nakanishi T; Nishii R; Fukuchi K; Tamai I; Kawai K
    Pharm Res; 2018 Nov; 36(1):18. PubMed ID: 30498970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited modulation of the transport activity of the human multidrug resistance proteins MRP1, MRP2 and MRP3 by nicotine glucuronide metabolites.
    Létourneau IJ; Bowers RJ; Deeley RG; Cole SP
    Toxicol Lett; 2005 May; 157(1):9-19. PubMed ID: 15795089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters.
    Yang J; Zhang B; Qin Z; Li S; Xu J; Yao Z; Zhang X; Gonzalez FJ; Yao X
    Biofactors; 2018 Nov; 44(6):558-569. PubMed ID: 30334318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells.
    Nakatomi K; Yoshikawa M; Oka M; Ikegami Y; Hayasaka S; Sano K; Shiozawa K; Kawabata S; Soda H; Ishikawa T; Tanabe S; Kohno S
    Biochem Biophys Res Commun; 2001 Nov; 288(4):827-32. PubMed ID: 11688982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.